Skip to main content

Table 2 Characteristics of T0 human breast tumors

From: Expression of Molecular Biomarkers in Primary Breast Tumors Implanted into a Surrogate Host: Increased Levels of Cyclins Correlate with Tumor Progression

Tissue Cyclin D1a Cyclin D3a Estrogen Receptora p53a C-erbB-2a Xenograft Growthb
037 76.0 ± 0.2 66.2 ± 2.9 87.0 ± 0.4 75.0 ± 0.6 80.0 ± 2.5 +
195 77.3 ± 0.5 70.0 ± 0.5 84.5 ± 0.9 60.5 ± 3.2 75.0 ± 0.3 +
118 0.0 0.0 0.0 57.5 ± 0.5 19.3 ± 1.7
003 11.5 ± 1.4 46 ± 1.2 39.0 ± 5.2 66.6 ± 3.0 56.0 ± 2.8
089 0.0 0.0 0.0 0.0 15.5 ± 1.7
062 10.8 ± 1.2 0.0 16.0 ± 2.8 0.0 13.0 ± 2.1
337 12.0 ± 2.3 0.0 74.0 ± 0.6 10.5 ± 0.2 52.0 ± 2.0
  1. aPercent of cells ± SEM exhibiting moderate to strong stain for antibody.
  2. bT1 tumor growth was positive (+) when a nodule at the site of the transplant was visible within 2 weeks. Growth was negative (−) when the tumor was absorbed by host.